Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
7
×
biotech
national top stories
new york blog main
san francisco top stories
boston blog main
boulder/denver blog main
new york top stories
san diego blog main
san diego top stories
startups
boston top stories
boulder/denver top stories
detroit blog main
detroit top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
amgen
deals
gilead sciences
glaxosmithkline
indiana blog main
indiana top stories
novartis
pfizer
adverum biotechnologies
alzheimer's disease
astrazeneca
biogen
cancer
What
ceo
7
×
bio
drug
roundup
acquisitions
week
announced
big
biggest
company
crispr
daniel
financing
gilead
medical
medicine
medicines
moves
new
o’day
raised
sciences
year
aces
adds
albert
analyzes
athena
biotech
bosley's
bosley’s
bourla
bridge
bucks
build
buy
cancer
cas
chief
cholesterol
Language
unset
unknown
Current search:
" san francisco blog main "
×
ceo
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO